Traumatic Brain Injury Therapeutics Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4115596
- 134 Pages
- November 2020
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Traumatic Brain Injury Therapeutics market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Traumatic Brain Injury Therapeutics market segmented into
Acetylcholinesterase Inhibitors
Erythropoietin
Growth Hormone
Stem Cells
Others
Based on the end-use, the global Traumatic Brain Injury Therapeutics market classified into
Focal TBI
Open TBI
Closed TBI
Diffuse TBI
Primary TBI
Others
Based on geography, the global Traumatic Brain Injury Therapeutics market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
SFC Fluidics LLC
Banayan Biomarkers Inc.
BHR Pharma LLC
Cerora Inc.
ElMindA Ltd.
Grace Laboratories LLC
KeyNeurotek Pharmaceuticals AG
Luoxis Diagnostics
Neuro Assessment Systems
Neurovive Pharmaceuticals AB
Oxygen Biotherapeutics Inc.
Phlogistix LLC
Neurohealing Pharmaceuticals
Neuren Pharmaceuticals Ltd.
Remedy Pharmaceuticals Inc.
Biodirection Inc.
Brainscope Company Inc.
TEVA Pharmaceutical Industries Ltd.
Vasopharm
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL TRAUMATIC BRAIN INJURY THERAPEUTICS INDUSTRY
2.1 Summary about Traumatic Brain Injury Therapeutics Industry
2.2 Traumatic Brain Injury Therapeutics Market Trends
2.2.1 Traumatic Brain Injury Therapeutics Production & Consumption Trends
2.2.2 Traumatic Brain Injury Therapeutics Demand Structure Trends
2.3 Traumatic Brain Injury Therapeutics Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Acetylcholinesterase Inhibitors
4.2.2 Erythropoietin
4.2.3 Growth Hormone
4.2.4 Stem Cells
4.2.5 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Focal TBI
4.3.2 Open TBI
4.3.3 Closed TBI
4.3.4 Diffuse TBI
4.3.5 Primary TBI
4.3.6 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Acetylcholinesterase Inhibitors
5.2.2 Erythropoietin
5.2.3 Growth Hormone
5.2.4 Stem Cells
5.2.5 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Focal TBI
5.3.2 Open TBI
5.3.3 Closed TBI
5.3.4 Diffuse TBI
5.3.5 Primary TBI
5.3.6 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Acetylcholinesterase Inhibitors
6.2.2 Erythropoietin
6.2.3 Growth Hormone
6.2.4 Stem Cells
6.2.5 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Focal TBI
6.3.2 Open TBI
6.3.3 Closed TBI
6.3.4 Diffuse TBI
6.3.5 Primary TBI
6.3.6 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Acetylcholinesterase Inhibitors
7.2.2 Erythropoietin
7.2.3 Growth Hormone
7.2.4 Stem Cells
7.2.5 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Focal TBI
7.3.2 Open TBI
7.3.3 Closed TBI
7.3.4 Diffuse TBI
7.3.5 Primary TBI
7.3.6 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Acetylcholinesterase Inhibitors
8.2.2 Erythropoietin
8.2.3 Growth Hormone
8.2.4 Stem Cells
8.2.5 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Focal TBI
8.3.2 Open TBI
8.3.3 Closed TBI
8.3.4 Diffuse TBI
8.3.5 Primary TBI
8.3.6 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Acetylcholinesterase Inhibitors
9.2.2 Erythropoietin
9.2.3 Growth Hormone
9.2.4 Stem Cells
9.2.5 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Focal TBI
9.3.2 Open TBI
9.3.3 Closed TBI
9.3.4 Diffuse TBI
9.3.5 Primary TBI
9.3.6 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 SFC Fluidics LLC
10.1.2 Banayan Biomarkers Inc.
10.1.3 BHR Pharma LLC
10.1.4 Cerora Inc.
10.1.5 ElMindA Ltd.
10.1.6 Grace Laboratories LLC
10.1.7 KeyNeurotek Pharmaceuticals AG
10.1.8 Luoxis Diagnostics
10.1.9 Neuro Assessment Systems
10.1.10 Neurovive Pharmaceuticals AB
10.1.11 Oxygen Biotherapeutics Inc.
10.1.12 Phlogistix LLC
10.1.13 Neurohealing Pharmaceuticals
10.1.14 Neuren Pharmaceuticals Ltd.
10.1.15 Remedy Pharmaceuticals Inc.
10.1.16 Biodirection Inc.
10.1.17 Brainscope Company Inc.
10.1.18 TEVA Pharmaceutical Industries Ltd.
10.1.19 Vasopharm
10.2 Traumatic Brain Injury Therapeutics Sales Date of Major Players (2017-2020e)
10.2.1 SFC Fluidics LLC
10.2.2 Banayan Biomarkers Inc.
10.2.3 BHR Pharma LLC
10.2.4 Cerora Inc.
10.2.5 ElMindA Ltd.
10.2.6 Grace Laboratories LLC
10.2.7 KeyNeurotek Pharmaceuticals AG
10.2.8 Luoxis Diagnostics
10.2.9 Neuro Assessment Systems
10.2.10 Neurovive Pharmaceuticals AB
10.2.11 Oxygen Biotherapeutics Inc.
10.2.12 Phlogistix LLC
10.2.13 Neurohealing Pharmaceuticals
10.2.14 Neuren Pharmaceuticals Ltd.
10.2.15 Remedy Pharmaceuticals Inc.
10.2.16 Biodirection Inc.
10.2.17 Brainscope Company Inc.
10.2.18 TEVA Pharmaceutical Industries Ltd.
10.2.19 Vasopharm
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Traumatic Brain Injury Therapeutics Product Type Overview
2.Table Traumatic Brain Injury Therapeutics Product Type Market Share List
3.Table Traumatic Brain Injury Therapeutics Product Type of Major Players
4.Table Brief Introduction of SFC Fluidics LLC
5.Table Brief Introduction of Banayan Biomarkers Inc.
6.Table Brief Introduction of BHR Pharma LLC
7.Table Brief Introduction of Cerora Inc.
8.Table Brief Introduction of ElMindA Ltd.
9.Table Brief Introduction of Grace Laboratories LLC
10.Table Brief Introduction of KeyNeurotek Pharmaceuticals AG
11.Table Brief Introduction of Luoxis Diagnostics
12.Table Brief Introduction of Neuro Assessment Systems
13.Table Brief Introduction of Neurovive Pharmaceuticals AB
14.Table Brief Introduction of Oxygen Biotherapeutics Inc.
15.Table Brief Introduction of Phlogistix LLC
16.Table Brief Introduction of Neurohealing Pharmaceuticals
17.Table Brief Introduction of Neuren Pharmaceuticals Ltd.
18.Table Brief Introduction of Remedy Pharmaceuticals Inc.
19.Table Brief Introduction of Biodirection Inc.
20.Table Brief Introduction of Brainscope Company Inc.
21.Table Brief Introduction of TEVA Pharmaceutical Industries Ltd.
22.Table Brief Introduction of Vasopharm
23.Table Products & Services of SFC Fluidics LLC
24.Table Products & Services of Banayan Biomarkers Inc.
25.Table Products & Services of BHR Pharma LLC
26.Table Products & Services of Cerora Inc.
27.Table Products & Services of ElMindA Ltd.
28.Table Products & Services of Grace Laboratories LLC
29.Table Products & Services of KeyNeurotek Pharmaceuticals AG
30.Table Products & Services of Luoxis Diagnostics
31.Table Products & Services of Neuro Assessment Systems
32.Table Products & Services of Neurovive Pharmaceuticals AB
33.Table Products & Services of Oxygen Biotherapeutics Inc.
34.Table Products & Services of Phlogistix LLC
35.Table Products & Services of Neurohealing Pharmaceuticals
36.Table Products & Services of Neuren Pharmaceuticals Ltd.
37.Table Products & Services of Remedy Pharmaceuticals Inc.
38.Table Products & Services of Biodirection Inc.
39.Table Products & Services of Brainscope Company Inc.
40.Table Products & Services of TEVA Pharmaceutical Industries Ltd.
41.Table Products & Services of Vasopharm
42.Table Market Distribution of Major Players
43.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
44.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
45.Table Global Traumatic Brain Injury Therapeutics Market Forecast (Million USD) by Region 2021f-2026f
46.Table Global Traumatic Brain Injury Therapeutics Market Forecast (Million USD) Share by Region 2021f-2026f
47.Table Global Traumatic Brain Injury Therapeutics Market Forecast (Million USD) by Demand 2021f-2026f
48.Table Global Traumatic Brain Injury Therapeutics Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
